Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 497 | 651 | 509 | 448 | 522 |
| Gross Profit | 497 | 651 | 509 | 448 | 522 |
| Operating Expenses | 54,353 | 65,770 | 67,269 | 68,656 | 63,896 |
| Operating Income | -53,856 | -65,119 | -66,760 | -68,208 | -63,374 |
| Other Income | 4,040 | 4,666 | 5,011 | 3,894 | 4,152 |
| Pre-tax Income | -49,816 | -60,453 | -61,749 | -64,314 | -59,222 |
| Income Tax | N/A | 242 | 240 | 109 | 87 |
| Net Income Continuous | -49,816 | -60,695 | -61,989 | -64,423 | -59,309 |
| Net Income | $-49,816 | $-60,695 | $-61,989 | $-64,423 | $-59,309 |
| EPS Basic Total Ops | -0.83 | -0.91 | -1.04 | -1.43 | -1.33 |
| EPS Basic Continuous Ops | -0.83 | -0.91 | -1.04 | -1.43 | -1.33 |
| EPS Diluted Total Ops | -0.83 | -0.91 | -1.04 | -1.43 | -1.33 |
| EPS Diluted Continuous Ops | -0.83 | -0.91 | -1.04 | -1.43 | -1.33 |
| EPS Diluted Before Non-Recurring Items | -0.83 | -1.01 | -1.04 | N/A | N/A |
| EBITDA(a) | $-53,943 | $-64,927 | $-66,853 | $-68,347 | $-64,197 |